Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 113

1.

Early clinical studies with lapachol (NSC-11905).

Block JB, Serpick AA, Miller W, Wiernik PH.

Cancer Chemother Rep 2. 1974 Dec;4(4):27-8. No abstract available.

PMID:
4614904
2.

Quinone natural products: streptonigrin (NSC-45383) and lapachol (NSC-11905) structure-activity relationships.

Rao KV.

Cancer Chemother Rep 2. 1974 Dec;4(4):11-7. No abstract available.

PMID:
4451909
3.

[Clinical experience report on the use of a new cytostatic 3393].

Anger G, Hesse P, Köhler P, Baufeld H.

Z Gesamte Inn Med. 1968 Apr 15;23(8):242-7. German. No abstract available.

PMID:
4883140
4.

[Antimicrobial substances from higher plants. XXXV. Antimicrobial or antineoplastic activity of lawsona (2-hydroxy-1,4-naphthoquinone) in comparison with lapachol (2-hydroxy-3-(-3-methyl-2-butanyl)-1,4-naphthoquinone].

de Lime OG, Coêlho JS, d' Albuquerque IL, de Mello JF, Martins DG, Lacerda AL, de Moraes e Souza MA.

Rev Inst Antibiot (Recife). 1971 Jun;11(1):21-6. Portuguese. No abstract available.

PMID:
5161607
5.

Discontinued drugs in 2007: oncology drugs.

Williams R.

Expert Opin Investig Drugs. 2008 Dec;17(12):1791-816. doi: 10.1517/13543780802465737 .

PMID:
19012497
6.

Acute myeloid leukemia in children: a review of risk factors and recent trials.

Gregory J, Arceci R.

Cancer Invest. 2002;20(7-8):1027-37. Review. No abstract available.

PMID:
12449736
7.

Recent advances in cancer chemotherapy.

Speechley V.

Nursing (Lond). 1987 Aug;3(20):743-7. No abstract available.

PMID:
3313128
8.

The silent revolution in childhood cancer.

Quah TC.

Singapore Med J. 1998 Mar;39(3):89-90. No abstract available.

PMID:
9632963
9.

Incorporating novel treatment strategies into conventional therapy.

Estey EH.

Clin Adv Hematol Oncol. 2009 Jun;7(6):4-7. Review. No abstract available.

PMID:
19645129
10.

Use of new chemotherapeutic agents in acute and chronic myeloid leukemia.

Quattrin N, Dini E.

Acta Genet Med Gemellol (Roma). 1968 Jan;17(1):255-7. No abstract available.

PMID:
4873071
11.

[Antitumoral and toxicological properties of extracts of bark and various wood components of Pau d'arco (Tabebuia avellanedae)].

de Santana CF, de Lima Og, d' Albuquerque IL, Lacerda AL, Martins DG.

Rev Inst Antibiot (Recife). 1968 Dec;8(1):89-94. Portuguese. No abstract available.

PMID:
5761014
12.

Demonstration of the lapachol as a potential drug for reducing cancer metastasis.

Balassiano IT, De Paulo SA, Henriques Silva N, Cabral MC, da Gloria da Costa Carvalho M.

Oncol Rep. 2005 Feb;13(2):329-33.

PMID:
15643520
13.

Intermittent guanazole therapy in adult acute leukemia.

Hewlett JS, Bodey GP, Coltman CA, Freireich EJ, Haut AB, McCredie KB.

Clin Pharmacol Ther. 1973 Mar-Apr;14(2):271-6. No abstract available.

PMID:
4571981
14.

Dibromomannitol and chronic myeloid leukaemia results of a cooperative study.

[No authors listed]

Haematologica. 1972 Apr;57(11):732-40. No abstract available.

PMID:
4200308
15.

Clinical trials referral resource. Update on taxol trials.

Cheson BD.

Oncology (Williston Park). 1993 Jan;7(1):63, 66-7. No abstract available.

PMID:
8093592
16.

Clinical trials in adult AML.

Stock W.

Clin Adv Hematol Oncol. 2009 Jun;7(6):8-10. Review. No abstract available.

PMID:
19645130
17.

Cloretazine for the treatment of acute myeloid leukemia.

Vey N, Giles F.

Expert Rev Anticancer Ther. 2006 Mar;6(3):321-8. Review.

PMID:
16503849
18.

[Experiences with Carnivora].

Dietzel U, Sauer R, Reichardt U.

Fortschr Med. 1985 Aug 29;103(31-32):760-1. German. No abstract available.

PMID:
3902598
19.

Preliminary pharmacologic and clinical evaluation of camptothecin sodium (NSC-100880).

Gottlieb JA, Guarino AM, Call JB, Oliverio VT, Block JB.

Cancer Chemother Rep. 1970 Dec;54(6):461-70. No abstract available.

PMID:
4946015
20.

[The most recent research results confirm the safety and effectiveness of iscador in cancer].

[No authors listed]

Krankenpfl J. 2004;42(5-6):160-1. German. No abstract available.

PMID:
15527225

Supplemental Content

Support Center